As on May 18, 2021, Fortress Biotech Inc. (NASDAQ: FBIO) got off with the flyer as it spiked 5.93% to $3.75. During the day, the stock rose to $3.93 and sunk to $3.48 before settling in for the price of $3.54 at the close. Taking a more long-term approach, FBIO posted a 52-week range of $2.12-$6.10.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 121.10%. Meanwhile, its Annual Earning per share during the time was 12.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 11.50%. This publicly-traded company’s shares outstanding now amounts to $79.81 million, simultaneously with a float of $66.45 million. The organization now has a market capitalization sitting at $357.79 million. At the time of writing, stock’s 50-day Moving Average stood at $4.12, while the 200-day Moving Average is $3.54.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 111 employees. It has generated 410,802 per worker during the last fiscal year. Meanwhile, its income per employee was -419,153. The stock had 2.64 Receivables turnover and 0.16 Total Asset turnover. For the Profitability, stocks gross margin was +62.99, operating margin was -206.74 and Pretax Margin of -225.55.
Fortress Biotech Inc. (FBIO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Fortress Biotech Inc.’s current insider ownership accounts for 26.30%, in contrast to 33.90% institutional ownership. According to the most recent insider trade that took place on Mar 02, this organization’s Director sold 10,000 shares at the rate of 4.45, making the entire transaction reach 44,500 in total value, affecting insider ownership by 720,000. Preceding that transaction, on Feb 19, Company’s Director sold 8,000 for 4.31, making the whole transaction’s value amount to 34,480. This particular insider is now the holder of 730,000 in total.
Fortress Biotech Inc. (FBIO) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 12/31/2020, the company posted -$0.05 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.14) by $0.09. This company achieved a net margin of -102.03 while generating a return on equity of -73.53. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
Fortress Biotech Inc.’s EPS increase for this current 12-month fiscal period is 11.50% and is forecasted to reach 0.34 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 25.50% through the next 5 years, which can be compared against the 12.20% growth it accomplished over the previous five years trading on the market.
Fortress Biotech Inc. (NASDAQ: FBIO) Trading Performance Indicators
Let’s observe the current performance indicators for Fortress Biotech Inc. (FBIO). It’s Quick Ratio in the last reported quarter now stands at 5.40. The Stock has managed to achieve an average true range (ATR) of 0.36. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.85.
In the same vein, FBIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.66, a figure that is expected to reach -0.16 in the next quarter, and analysts are predicting that it will be 0.34 at the market close of one year from today.
Technical Analysis of Fortress Biotech Inc. (FBIO)
Through scrutinizing the latest numbers posted by the [Fortress Biotech Inc., FBIO], it can be observed that its last 5-days Average volume of 0.79 million was lower the volume of 1.53 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 25.95% While, its Average True Range was 0.31.
Raw Stochastic average of Fortress Biotech Inc. (FBIO) in the period of the previous 100 days is set at 23.95%, which indicates a major rise in contrast to 22.39% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 63.24% that was lower than 87.36% volatility it exhibited in the past 100-days period.